全文获取类型
收费全文 | 3699篇 |
免费 | 374篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 212篇 |
妇产科学 | 108篇 |
基础医学 | 179篇 |
口腔科学 | 165篇 |
临床医学 | 536篇 |
内科学 | 1096篇 |
皮肤病学 | 35篇 |
神经病学 | 118篇 |
特种医学 | 18篇 |
外科学 | 722篇 |
综合类 | 108篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 345篇 |
眼科学 | 40篇 |
药学 | 220篇 |
中国医学 | 12篇 |
肿瘤学 | 183篇 |
出版年
2024年 | 11篇 |
2023年 | 122篇 |
2022年 | 79篇 |
2021年 | 175篇 |
2020年 | 172篇 |
2019年 | 206篇 |
2018年 | 216篇 |
2017年 | 173篇 |
2016年 | 174篇 |
2015年 | 157篇 |
2014年 | 202篇 |
2013年 | 358篇 |
2012年 | 162篇 |
2011年 | 175篇 |
2010年 | 141篇 |
2009年 | 167篇 |
2008年 | 141篇 |
2007年 | 139篇 |
2006年 | 135篇 |
2005年 | 117篇 |
2004年 | 99篇 |
2003年 | 95篇 |
2002年 | 79篇 |
2001年 | 69篇 |
2000年 | 50篇 |
1999年 | 41篇 |
1998年 | 41篇 |
1997年 | 43篇 |
1996年 | 29篇 |
1995年 | 31篇 |
1994年 | 29篇 |
1993年 | 20篇 |
1992年 | 29篇 |
1991年 | 20篇 |
1990年 | 21篇 |
1989年 | 16篇 |
1988年 | 22篇 |
1987年 | 22篇 |
1986年 | 21篇 |
1985年 | 17篇 |
1984年 | 23篇 |
1983年 | 15篇 |
1982年 | 5篇 |
1981年 | 18篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1973年 | 2篇 |
排序方式: 共有4117条查询结果,搜索用时 15 毫秒
71.
72.
《Actas urologicas espa?olas》2014,38(6):391-396
Objectiveprostate biopsy is the standardized diagnostic method for prostate cancer. However, although there is not a standardized protocol, there are recommendations in order to reduce the incidence of complications. The objective of the present work is to assess the efficacy and safety of antibiotic prophylaxis in the prostate biopsy by comparing two antibiotic regimes: two doses of fosfomycin-trometamol 3 g (FMT) every 48 hours with 10 doses of oral ciprofloxacin 500 mg every 12 hours during 5 days.Material and methodsrandomized prospective study was performed with 671 patients who had undergone to walking transrectal ultrasound guided prostate biopsy. Patients of group A (n = 312) were treated with ciprofloxacin, and patients of group B (n = 359) with FMT. Efficacy and tolerability of two prophylactic regimes were compared. Urine culture was carried out at 2 weeks after biopsy. Initially, patients with asymptomatic bacteriuria were not treated with antibiotics; urine culture was repeated after 1 month, persistent bacteriuria was treated according to antibiogram.Resultsno differences between groups were found in age (P = .78), cancer presence (P = .9) or number of biopsy cylinders (P = .93). The mean number of cores obtained was 11.3 ± 3.25 (range 6-20). Digestive intolerance was observed for 9 patients (2.9%) of group A and 10 patients (2.8%) in group B. One patient (.3%) of group A showed severe allergic reaction. In total, 167 patients (24.6%) had complications: 16 (2.4%) fever, 47 (6.9%) hemospermia, 81 (11.9%) hematuria, 7 (1%) rectal bleeding and 16 (2.4%) urinary retention. No statistically differences between groups were observed (27.6% vs. 22.6%; P = .17). However, hemospermia was more frequent in group A (9.9% vs. 4.5%; P = .006). Bacteriuria after biopsy was detected in 44 patients (6.6%), being more frequent in group B patients (4.2% vs. 8.6%; P = .02) although a higher number of second treatment cycles were not needed (53.9% vs. 29%; P = .17). The likelihood of resistance to ciprofloxacin in patients with bacteriuria in A was greater than that of FMT in B (69.2% vs. 41.9%; P = .0004).Conclusionsantibiotic prophylaxis with FMT (2 doses of 3 g) in prostate biopsy is an alternative as effective and safe as ciprofloxacin (10 doses of 500 mg), which carries lower rate of resistance. According to our experience, this drug is a safe, well-tolerated, and easily manageable prophylactic option, facilitating patient compliance. More prospective multicenter studies are necessary to confirm these findings. 相似文献
73.
Diane Santa Maria Charlene A. Flash Sarah Narendorf Anamika Barman-Adhikari Robin Petering Hsun-Ta Hsu Jama Shelton Kimberly Bender Kristin Ferguson 《The Journal of adolescent health》2019,64(5):574-580
Purpose
Evidence suggests that young adults experiencing homelessness (YEH) are at elevated risk of HIV compared to housed youth. Given the limited research on pre-exposure prophylaxis (PrEP) awareness among YEH, this study examined their PrEP knowledge and attitudes.Methods
Data from a cross-sectional survey among YEH (ages 18–26) (n?=?1,427) in seven U.S. cities were used to assess their knowledge and attitudes regarding PrEP to inform HIV prevention efforts.Results
Participants were primarily male youth of color. The mean age was 20.9years. While 66% felt at risk for HIV, only 14% strongly agreed that they try to protect themselves from getting infected with HIV. Most (84%) were eligible for PrEP based on risk, yet only 29% had knowledge of PrEP. Despite this, 59% reported they were likely/extremely likely to take PrEP. Access to free PrEP (55%), HIV testing (72%), healthcare (68%), and one-on-one (62%), and text messaging support (57%) were rated as very/extremely important for PrEP uptake and adherence.Conclusions
The results of this study suggest missed opportunities to prevent new HIV infections among YEH. Efforts to increase PrEP uptake among this population should consider provider- and system-level interventions to increase PrEP awareness, decrease PrEP-associated healthcare costs, improve access to PrEP providers, and provide in-person and text messaging support. 相似文献74.
Deven T. Hamilton Eli S. Rosenberg Patrick S. Sullivan Li Yan Wang Richard L. Dunville Lisa C. Barrios Maria Aslam Brian Mustanski Steven M. Goodreau 《The Journal of adolescent health》2021,68(3):488-496
PurposePre-exposure prophylaxis (PrEP)—an effective and safe intervention to prevent HIV transmission—was recently approved by the Food and Drug Administration for use by adolescents. Informed by studies of sexual behavior and PrEP adherence, retention, and promotion, we model the potential impact of PrEP use among at-risk adolescent sexual minority males.MethodsWe simulate an HIV epidemic among men who have sex with men (MSM) aged 13–39. We assume adult MSM ages 19–39 have had PrEP available for 3 years with 20% coverage among eligible MSM based on the Centers for Disease Control and Prevention guidelines. PrEP interventions for ages 16–18 are then simulated using adherence and retention profiles drawn from the ATN113 and Enhancing Preexposure Prophylaxis in Community studies across a range of uptake parameters (10%–100%). Partnerships across age groups were modeled using parameterizations from the RADAR study. We compare the percent of incident infections averted (impact), person-years on PrEP per infection averted (efficiency), and changes in prevalence over 10 years.ResultsAs compared to no PrEP use, baseline PrEP adherence and retention among adolescent sexual minority males drawn from the ATN113 and Enhancing Preexposure Prophylaxis in Community studies averted from 2.8% to 41.0% of HIV infections depending on the fraction of eligible adolescent sexual minority males that initiated PrEP at their annual health-care visit. Improved adherence and retention achieved with an array of focused interventions from real-world settings increased the percent of infections averted by as much as 26%–70%.ConclusionsEmpirically demonstrated improvements in the PrEP continuum of care in response to existing interventions can substantially reduce incident HIV infections among adolescent sexual minority males. 相似文献
75.
76.
《Biology of blood and marrow transplantation》2014,20(8):1080-1088
This document updates and expands the recommendations on primary prophylaxis of invasive fungal diseases (IFD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, published in 2009 by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). A consensus process was undertaken to describe and evaluate current information and practice regarding risk stratification and primary antifungal prophylaxis during the pre-engraftment and postengraftment phases after allo-HSCT. The revised recommendations were based on the evaluation of recent literature including a large, prospective, multicenter epidemiological study of allo-HSCT recipients conducted among the GITMO transplantation centers during the period of 2008 to 2010. It is intended as a guide for the identification of types and phases of transplantation at low, standard, and high risk for IFD, according to the underlying disease, transplantation, and post-transplantation factors. The risk stratification was the critical determinant of the primary antifungal approach for allo-HSCT recipients. 相似文献
77.
《The journal of maternal-fetal & neonatal medicine》2013,26(9):1660-1663
Background: As the vitamin K content of human milk is low and the newborn infant's stores of vitamin K are small, vitamin K deficiency with hemorrhage in the newborn is a worldwide problem. Proteins Induced by Vitamin K Absence (PIVKA-II) are the inactive under-γ-carboxylated forms of vitamin K-dependent clotting factors and they could be useful in predicting subclinical vitamin K deficiency (VKD). Objectives: To demonstrate that PIVKA-II are earlier markers of subclinical VKD than Prothrombin time (PT) in exclusively breast-fed newborns. Methods: A prospective, controlled, randomized study, including 53 term newborns receiving vitamin K prophylaxis (0.5 mg i.m.) at birth, was performed. At 30 days newborns were divided into three groups (G) receiving respectively: 25 μg/die of vitamin K (G I), 12 μg/die (G II) or placebo (G III). PIVKA-II and PT were measured on 30th and 90th days of life. Results: G III and GII showed a significant increase in PIVKA-II from 30 to 90 days of life respectively from 2.6 to 4.7 (p = 0.001) and from 2.3 to 3.5 (p < 0.001). No significant changes were found in GI. PT showed no significant changes among groups. Conclusions: PT is a less sensitive marker than PIVKA II. Oral supplementation with 25 μg/die avoids an increase of PIVKA-II. Despite increased PIVKA-II do not mean an impending occurrence of bleeding, they highlight a subclinical VKD and its relative risk. 相似文献
78.
《Expert review of anti-infective therapy》2013,11(5):761-769
Solid-organ transplantation has become a widely accepted treatment modality for end-stage diseases. With the advent of newer and more potent immunosuppressive regimens, graft survival has improved, but at the expense of an increased risk for the development of infections secondary to bacterial, fungal, viral and parasitic pathogens. Prevention of such infectious complications with effective, well-tolerated and cost-effective antimicrobials would be ideal to improve the outcome of transplant patients. Cytomegalovirus is the most common cause of viral infections. Herpes simplex virus, Varicella-zoster virus, Epstein–Barr virus and others are also significant pathogens. Fungal infections are associated with the highest mortality rates. This review summarizes the most relevant data pertaining to the current understanding of infection prevention for solid-organ transplant recipients. 相似文献
79.